AHNAK and gastric cancer: Similarly, this microRNA has been found to be upregulated in gastric cancer (162, 163) and expression correlates with poor survival and metastatic disease (164, 165), Transfection and overexpression of miRNA-93 in gastric cancer cell lines also promotes an increase in proliferation, migration, invasion and chemoresistance (166, 167) and decreases the expression of the tumour suppressors AHNAK (167, 168) and TIMP-2 (165).